{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T20:26:03Z","timestamp":1794255963385,"version":"4.9.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s00401-011-0900-5","type":"journal-article","created":{"date-parts":[[2011,11,5]],"date-time":"2011-11-05T03:27:10Z","timestamp":1320463630000},"page":"235-245","source":"Crossref","is-referenced-by-count":99,"title":["Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy"],"prefix":"10.1007","volume":"123","author":[{"given":"Imke","family":"Metz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernst-Wilhelm","family":"Radue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agustin","family":"Oterino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"K\u00fcmpfel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Wiendl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Schippling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Kuhle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ali","family":"Sahraian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francoise","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Jakl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darius","family":"H\u00e4usler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Br\u00fcck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,11,6]]},"reference":[{"key":"900_CR1","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2165\/11537510-000000000-00000","volume":"33","author":"JR Berger","year":"2010","unstructured":"Berger JR (2010) Progressive multifocal leucoencephalopathy and newer biological agents. Drug Saf 33:969\u2013983","journal-title":"Drug Saf"},{"key":"900_CR2","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S1474-4422(10)70028-4","volume":"9","author":"DB Clifford","year":"2010","unstructured":"Clifford DB, De LA, Simpson DM, Arendt G, Giovannoni G, Nath A (2010) Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases. Lancet Neurol 9:438\u2013446","journal-title":"Lancet Neurol"},{"key":"900_CR3","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1093\/brain\/awh215","volume":"127","author":"RA Du Pasquier","year":"2004","unstructured":"Du Pasquier RA, Kuroda MJ, Zheng Y, Jean-Jacques J, Letvin NL, Koralnik IJ (2004) A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy. Brain 127:1970\u20131978","journal-title":"Brain"},{"key":"900_CR4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000109933","volume":"5","author":"B Engelhardt","year":"2008","unstructured":"Engelhardt B, Kappos L (2008) Natalizumab: targeting alpha4-integrins in multiple sclerosis. Neurodegener Dis 5:16\u201322","journal-title":"Neurodegener Dis"},{"key":"900_CR5","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/00002030-200307040-00004","volume":"17","author":"J Gasnault","year":"2003","unstructured":"Gasnault J, Kahraman M, de Herve MG, Durali D, Delfraissy JF, Taoufik Y (2003) Critical role of JC virus-specific CD4 T-cell responses in preventing progressive multifocal leukoencephalopathy. AIDS 17:1443\u20131449","journal-title":"AIDS"},{"key":"900_CR6","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1084\/jem.188.12.2199","volume":"188","author":"SA Kalams","year":"1998","unstructured":"Kalams SA, Walker BD (1998) The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses. J Exp Med 188:2199\u20132204","journal-title":"J Exp Med"},{"key":"900_CR7","doi-asserted-by":"crossref","first-page":"4404","DOI":"10.1128\/JVI.02657-08","volume":"83","author":"N Khanna","year":"2009","unstructured":"Khanna N, Wolbers M, Mueller NJ, Garzoni C, Du Pasquier RA, Fux CA, Vernazza P, Bernasconi E, Viscidi R, Battegay M, Hirsch HH (2009) JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy. J Virol 83:4404\u20134411","journal-title":"J Virol"},{"key":"900_CR8","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1212\/01.wnl.0000341766.59028.9d","volume":"72","author":"BO Khatri","year":"2009","unstructured":"Khatri BO, Man S, Giovannoni G, Koo AP, Lee J-C, Tucky B, Lyon G, Jurgensen S, Woodworth J, Goelz S, Duda PW, Panzara MA, Ransohoff RM, Fox RJ (2009) Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function. Neurology 72:402\u2013409","journal-title":"Neurology"},{"key":"900_CR9","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1128\/JVI.75.7.3483-3487.2001","volume":"75","author":"IJ Koralnik","year":"2001","unstructured":"Koralnik IJ, Du Pasquier RA, Letvin NL (2001) JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy. J Virol 75:3483\u20133487","journal-title":"J Virol"},{"key":"900_CR10","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1212\/01.wnl.0000327671.91357.96","volume":"71","author":"M Krumbholz","year":"2008","unstructured":"Krumbholz M, Meinl I, Kumpfel T, Hohlfeld R, Meinl E (2008) Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis. Neurology 71:1350\u20131354","journal-title":"Neurology"},{"key":"900_CR11","doi-asserted-by":"crossref","unstructured":"Kuhle J, Gosert R, B\u00fchler R, Derfuss T, Sutter R, Yaldizli \u00d6, Radue E-W, Ryschkewitsch C, Major EO, Kappos L, Frank S, Hirsch HH (2011) Management and outcome of CSF\u2013JC virus PCR-negative PML in a natalizumab-treated MS patient. Neurology (in press)","DOI":"10.1212\/WNL.0b013e31823b9b27"},{"key":"900_CR12","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1212\/WNL.0b013e3181f07362","volume":"75","author":"T Lenhard","year":"2010","unstructured":"Lenhard T, Biller A, Mueller W, Metz I, Schonberger J, Wildemann B (2010) Immune reconstitution inflammatory syndrome after withdrawal of natalizumab? Neurology 75:831\u2013833","journal-title":"Neurology"},{"key":"900_CR13","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","volume":"47","author":"C Lucchinetti","year":"2000","unstructured":"Lucchinetti C, Br\u00fcck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47:707\u2013717","journal-title":"Ann Neurol"},{"key":"900_CR14","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1056\/NEJMp0906248","volume":"361","author":"EO Major","year":"2009","unstructured":"Major EO (2009) Reemergence of PML in natalizumab-treated patients\u2014new cases, same concerns. N Engl J Med 361:1041\u20131043","journal-title":"N Engl J Med"},{"key":"900_CR15","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1097\/00002030-200109280-00028","volume":"15","author":"P Miralles","year":"2001","unstructured":"Miralles P, Berenguer J, Lacruz C, Cosin J, Lopez JC, Padilla B, Munoz L, Garcia-de-Viedma D (2001) Inflammatory reactions in progressive multifocal leukoencephalopathy after highly active antiretroviral therapy. AIDS 15:1900\u20131902","journal-title":"AIDS"},{"key":"900_CR16","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1093\/jnen\/63.11.1124","volume":"63","author":"AM Munoz-Marmol","year":"2004","unstructured":"Munoz-Marmol AM, Mola G, Fernandez-Vasalo A, Vela E, Mate JL, Ariza A (2004) JC virus early protein detection by immunohistochemistry in progressive multifocal leukoencephalopathy: a comparative study with in situ hybridization and polymerase chain reaction. J Neuropathol Exp Neurol 63:1124\u20131130","journal-title":"J Neuropathol Exp Neurol"},{"key":"900_CR17","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1056\/NEJMoa044397","volume":"354","author":"CH Polman","year":"2006","unstructured":"Polman CH, O\u2018Connor PW, Havrdova E, Hutchinson M, Kappos L, Miller DH, Phillips JT, Lublin FD, Giovannoni G, Wajgt A, Toal M, Lynn F, Panzara MA, Sandrock AW (2006) A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 354:899\u2013910","journal-title":"N Engl J Med"},{"key":"900_CR18","first-page":"247","volume":"6","author":"EP Richardson Jr","year":"1975","unstructured":"Richardson EP Jr, Johnson PC (1975) Atypical progressive multifocal leukoencephalopathy with plasma-cell infiltrates. Acta Neuropathol Suppl 6:247\u2013250","journal-title":"Acta Neuropathol Suppl"},{"key":"900_CR19","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1086\/344056","volume":"35","author":"A Safdar","year":"2002","unstructured":"Safdar A, Rubocki RJ, Horvath JA, Narayan KK, Waldron RL (2002) Fatal immune restoration disease in human immunodeficiency virus type 1-infected patients with progressive multifocal leukoencephalopathy: impact of antiretroviral therapy-associated immune reconstitution. Clin Infect Dis 35:1250\u20131257","journal-title":"Clin Infect Dis"},{"key":"900_CR20","unstructured":"Sandrock A et al (2011) American Academy of Neurology Annual Meeting 2011, Poster\u2014AAN B03.248, Honolulu, Hawai, 21\u201328 April 2011"},{"key":"900_CR21","doi-asserted-by":"crossref","unstructured":"Schwab N, Hohn KG, Schneider-Hohendorf T, Metz I, Stenner MP, Jilek S, Du Pasquier RA, Gold R, Meuth SG, Ransohoff RM, Bruck W, Wiendl H (2011) Immunological and clinical consequences of treating a patient with natalizumab. Mult Scler (in press)","DOI":"10.1177\/1352458511421919"},{"key":"900_CR22","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.crad.2010.03.001","volume":"65","author":"R Shah","year":"2010","unstructured":"Shah R, Bag AK, Chapman PR, Cure JK (2010) Imaging manifestations of progressive multifocal leukoencephalopathy. Clin Radiol 65:431\u2013439","journal-title":"Clin Radiol"},{"key":"900_CR23","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1212\/WNL.0b013e31822e55e7","volume":"77","author":"IL Tan","year":"2011","unstructured":"Tan IL, McArthur JC, Clifford DB, Major EO, Nath A (2011) Immune reconstitution inflammatory syndrome in natalizumab-associated PML. Neurology 77:1061\u20131067","journal-title":"Neurology"},{"key":"900_CR24","unstructured":"Tysabri (2011) Corporate website. http:\/\/tysabri.de\/index.php?inhalt=tysabri.pmlinzidenz"},{"key":"900_CR25","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00401-005-0983-y","volume":"109","author":"A Vendrely","year":"2005","unstructured":"Vendrely A, Bienvenu B, Gasnault J, Thiebault JB, Salmon D, Gray F (2005) Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy. Acta Neuropathol 109:449\u2013455","journal-title":"Acta Neuropathol"},{"key":"900_CR26","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1086\/514032","volume":"176","author":"T Weber","year":"1997","unstructured":"Weber T, Trebst C, Frye S, Cinque P, Vago L, Sindic CJ, Schulz-Schaeffer WJ, Kretzschmar HA, Enzensberger W, Hunsmann G, Luke W (1997) Analysis of the systemic and intrathecal humoral immune response in progressive multifocal leukoencephalopathy. J Infect Dis 176:250\u2013254","journal-title":"J Infect Dis"},{"key":"900_CR27","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1056\/NEJMoa0810257","volume":"361","author":"W Wenning","year":"2009","unstructured":"Wenning W, Haghikia A, Laubenberger J, Clifford DB, Behrens PF, Chan A, Gold R (2009) Treatment of progressive multifocal leukoencephalopathy associated with natalizumab. N Engl J Med 361:1075\u20131080","journal-title":"N Engl J Med"},{"key":"900_CR28","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJMoa054693","volume":"354","author":"TA Yousry","year":"2006","unstructured":"Yousry TA, Major EO, Ryschkewitsch C, Fahle G, Fischer S, Hou J, Curfman B, Miszkiel K, Mueller-Lenke N, Sanchez E, Barkhof F, Radue EW, Jager HR, Clifford DB (2006) Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy. N Engl J Med 354:924\u2013933","journal-title":"N Engl J Med"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s00401-011-0900-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T23:47:23Z","timestamp":1560901643000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-011-0900-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,6]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["900"],"URL":"https:\/\/doi.org\/10.1007\/s00401-011-0900-5","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,6]]}}}